BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.37
0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT
BioCryst Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 557.51M | 503.49M | 450.71M | 412.58M | 382.24M | 355.39M | 331.41M | 317.56M | 306.64M | 289.68M | 270.83M | 238.44M | 203.61M | 188.03M | 157.17M | 114.03M | 79.14M | 32.05M |
Cost of Revenue | 16.73M | 15.98M | 12.68M | 8.61M | 6.51M | 5.41M | 5.08M | 5.52M | 8M | 7.29M | 6.59M | 4.52M | 1.52M | 1.61M | 7.3M | 6.96M | 7.87M | 35.03M |
Gross Profit | 540.78M | 487.82M | 438.35M | 404.29M | 375.62M | 349.16M | 325.5M | 311.21M | 298.24M | 282.39M | 264.23M | 233.92M | 202.09M | 186.42M | 149.87M | 107.07M | 71.26M | -2.98M |
Operating Income | 54.2M | 33.17M | -2.54M | -40.7M | -60.32M | -89.78M | -103.71M | -107.35M | -112.87M | -126.89M | -148.44M | -154.3M | -181.44M | -176.3M | -177.72M | -177.95M | -176.23M | -185.16M |
Interest Income | 12.7M | 13.74M | 14.75M | 15.64M | 16.23M | 16.43M | 15.78M | 14.02M | 11.59M | 8.45M | 5.13M | 2.44M | 686K | 90K | 62K | 576K | 567K | 3.31M |
Pretax Income | -32.19M | -51.18M | -86.95M | -124.13M | -146.5M | -208.58M | -226.23M | -234.53M | -239.71M | -223.13M | -244.38M | -188.44M | -206.25M | -191.44M | -181.81M | -226.78M | -214.09M | -209.5M |
Net Income | -35.71M | -53.47M | -88.88M | -123.82M | -145.93M | -208.59M | -226.54M | -236.35M | -242.72M | -226.25M | -247.12M | -193.35M | -209.63M | -193.97M | -184.06M | -226.78M | -214.09M | -209.5M |
Selling & General & Admin | 315.41M | 289.24M | 266.13M | 250.04M | 235.61M | 225.39M | 213.89M | 199.66M | 185.94M | 172.96M | 159.37M | 144.6M | 142.68M | 130.99M | 118.82M | 104.42M | 86.62M | 74.18M |
Research & Development | 171.18M | 165.41M | 174.64M | 195.25M | 201.05M | 214.67M | 216.57M | 219.72M | 225.58M | 236.32M | 253.3M | 243.62M | 240.85M | 231.73M | 208.81M | 180.63M | 160.91M | 135.53M |
Other Expenses | n/a | 35K | 162K | 162K | 162K | 127K | 7K | 7K | 7K | 7K | n/a | n/a | n/a | n/a | -36K | -36K | -36K | 24.64M |
Operating Expenses | 486.58M | 454.33M | 440.45M | 444.55M | 435.91M | 439.64M | 430.04M | 419.39M | 411.52M | 409.28M | 412.67M | 388.22M | 383.53M | 362.72M | 327.59M | 285.01M | 247.49M | 209.67M |
Interest Expense | 4.2M | 97.5M | 98.52M | 98.65M | 101.17M | 105.35M | 108.24M | 110.11M | 107.54M | 102.65M | 99.09M | 91.41M | 80.75M | 70.23M | 59.29M | 46.12M | 35.25M | 24.67M |
Selling & Marketing Expenses | n/a | n/a | n/a | 14.4M | 14.4M | 17.69M | 21.74M | 10.67M | 10.67M | 11.48M | 11.41M | 9.09M | 10.58M | 8.29M | 5.71M | -21.26M | -22.75M | -24.55M |
Cost & Expenses | 503.31M | 470.31M | 453.25M | 453.28M | 442.55M | 445.18M | 435.12M | 424.91M | 419.51M | 416.57M | 419.26M | 392.74M | 385.05M | 364.33M | 334.89M | 291.98M | 255.36M | 217.2M |
Income Tax Expense | 3.52M | 2.29M | 1.93M | -308K | -564K | 4K | 310K | 1.82M | 3.01M | 3.13M | 2.73M | 4.91M | 3.39M | 2.53M | 2.25M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 209.2M | 208.88M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 183.93M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
Shares Outstanding (Diluted) | 219.89M | 215.26M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 185.6M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
EPS (Basic) | -0.18 | -0.26 | -0.43 | -0.61 | -0.73 | -1.07 | -1.18 | -1.25 | -1.29 | -1.21 | -1.33 | -1.05 | -1.15 | -1.07 | -1.03 | -1.27 | -1.2 | -1.2 |
EPS (Diluted) | -0.18 | -0.26 | -0.43 | -0.61 | -0.73 | -1.07 | -1.18 | -1.25 | -1.29 | -1.21 | -1.33 | -1.05 | -1.15 | -1.07 | -1.03 | -1.27 | -1.2 | -1.2 |
EBITDA | -27.37M | 43.8M | 9.02M | -27.91M | -47.65M | -101.68M | -116.33M | -122.79M | -130.57M | -118.95M | -143.85M | -158.25M | -186.87M | -182.73M | -184.17M | -179.87M | -178.11M | -184.11M |
EBIT | 62.16M | 46.32M | 11.56M | -25.48M | -45.33M | -103.23M | -117.99M | -124.42M | -132.17M | -120.48M | -145.29M | -97.03M | -125.49M | -121.22M | -122.52M | -180.65M | -178.84M | -184.83M |
Depreciation & Amortization | 620K | 1.27M | 1.25M | 1.36M | 1.47M | 1.56M | 1.66M | 1.63M | 1.6M | 1.52M | 1.44M | 1.21M | 1.05M | 916K | 777K | 786K | 724K | 708K |